WASHINGTON, Feb 2 (Reuters) - The U.S. Trade Representative's Office said on Thursday it is seeking public comment on whether to restore tariffs on 81 Chinese medical product import categories related to the fight against COVID-19.
The trade agency said in a statement that it will ask interested parties for input on further extensions of exclusions from the Section 301 tariffs that have been extended through May 15. The exclusions, which were due to expire on Feb. 28, were initially granted in December 2020 and have been routinely extended several times since then as the pandemic wore on.
(Reporting by David Lawder; editing by Jonathan Oatis)
((David.Lawder@tr.com; +1 202 354 5854; Reuters Messaging: david.lawder.thomsonreuters.com@reuters.net))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.